Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 1 de 1
1.
Bioorg Med Chem ; 57: 116629, 2022 03 01.
Article En | MEDLINE | ID: mdl-35091169

Malaria is a prevalent and lethal disease. The fast emergence and spread of resistance to current therapies is a major concern and the development of a novel line of therapy that could overcome, the problem of drug resistance, is imperative. Screening of a set of compounds with drug/natural product-based sub-structural motifs led to the identification of spirocyclic chroman-4-one 1 with promising antimalarial activity against the chloroquine-resistant Dd2 and chloroquine-sensitive 3D7 strains of the parasite. Extensive structure-activity and structure-property relationship studies were conducted to identify the essential features necessary for its activity and properties.


Antimalarials/pharmacology , Chromans/pharmacology , Malaria/drug therapy , Plasmodium/drug effects , Spiro Compounds/pharmacology , Antimalarials/chemical synthesis , Antimalarials/chemistry , Cell Survival/drug effects , Chromans/chemical synthesis , Chromans/chemistry , Crystallography, X-Ray , Dose-Response Relationship, Drug , Hep G2 Cells , Humans , Models, Molecular , Molecular Structure , Parasitic Sensitivity Tests , Spiro Compounds/chemical synthesis , Spiro Compounds/chemistry , Structure-Activity Relationship
...